SCHEMBL97338

SCHEMBL97338

COc1ccc(CC2SC(=O)NC2=O)c2c1N(CC(=O)O)C(=O)CC2

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 2/20 0.49
▸ PTPN1 P18031 2/20 0.41
▸ MAPT P10636 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ PPARG P37231 3/20 0.34
▸ MPC2 O95563 1/20 0.34
▸ CYP2C8 P10632 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ FFAR1 O14842 2/20 0.33
▸ MAOA P21397 1/20 0.33
▸ CISD1 Q9NZ45 1/20 0.33
▸ PDE4B Q07343 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL98093 0.85 CA2 (0.45) CA2PTPN1MAPTHTTPPARG
SCHEMBL94894 0.84 CA2 (0.47) CA2PTPN1MAPTTSHRPPARG
SCHEMBL95205 0.83 CA2 (0.45) CA2PTPN1PPARGFFAR1PDE4B
SCHEMBL95628 0.83 MAPT (0.47) CA2PTPN1MAPTTSHRPPARG
SCHEMBL98238 0.83 CA2 (0.46) CA2PTPN1MAPTTSHRPPARG
SCHEMBL95913 0.83 CA2 (0.46) CA2PTPN1MAPTTSHRPPARG
SCHEMBL96109 0.83 CA2 (0.44) CA2PTPN1MAPTHTTPPARG
SCHEMBL13598459 0.82 MAPT (0.43) CA2MAPTPPARGMEN1KMT2A
SCHEMBL13598462 0.81 CA2 (0.43) CA2PTPN1MAPTKDM4EHTT
SCHEMBL13598447 0.81 CA2 (0.44) CA2PTPN1MAPTTSHRPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 — — US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 — — EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 — — EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 — — US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 — — US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 — — US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 — — EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 CA2 254/4885PTPN1 1691/4885MAPT 4773/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 CA2 254/4885PTPN1 1691/4885MAPT 4773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback